This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

WideMed Receives CE Certification for Mobile Sleep Apnea System II-32

WideMed Receives Order from GE Healthcare for Morpheus Hx Devices II-32

SleepQuest Buys Extra WatchPAT Devices from Itamar-Medical II-32

Coliseum Northside Hospital Opens Sleep Disorder Center II-32

Naturs Design Signs Partnership with Intus Healthcare II-33

Graymark Healthcare and Coryell Memorial Healthcare Ink Agreement II-33

Compumedics Obtains FDA Approval for GRAELâ„¢ HD-PSG Sllep System II-33

Covidien Sells Sleep Therapy and Bi-level Products to PH Invest II-33

Embla Snaps Up Covidien's Sleep Diagnostic Business II-33

Graymark Healthcare Signs Joint Venture Agreement with

Oklahoma Heart Hospital II-34

Ethicon Takes Over Acclarent II-34

Siix to Develop Sleep Disorders Tracking Device II-34

Blue Shield and Apria Healthcare Ink Agreement Group II-34

Peak Surgical Inks Distribution Agreement with Medtronic II-34

REM Medical, U.S. Health Works Enter into Partnership II-35

Graymark Healthcare Takes Over somniTech and somniCare II-35

ResMed Takes Over Laboratoires Narval II-35

Curative Medical Snaps Up BEVT II-35

Roadside Medical Clinic + Lab Enters into Joint Venture with

Sleep Pointe II-35

Air Liquide Takes Over Comcare Medical II-36

REM Medical Takes Over Tucson Site of PsyPharma Global II-36

Formation of CareFusion II-36

9. FOCUS ON SELECT PLAYERS II-37Grass Technologies (US) II-37Cadwell Laboratories, Inc. (US) II-37CareFusion Corporation ( USA) II-37Compumedics Ltd ( Australia) II-38DeVilbiss Healthcare (US) II-38Global Medical Holdings LLC (US) II-39Fisher & Paykel Healthcare Limited ( New Zealand) II-39GE Healthcare (US) II-39Vital Signs Inc. (US) II-39Itamar Medical Ltd. ( Israel) II-40Invacare Corporation (US) II-40Natus Medical Inc. (US) II-40Bio-Logic (US) II-40Embla Systems, Inc. (US) II-41Stellate Systems, Inc. ( Canada) II-41Philips Healthcare ( USA) II-41ResMed Inc. (US) II-42Teleflex Medical (US) II-42Weinmann Geräte für Medizin GmbH+CCo. KG ( Germany) II-42


Table 3: World Recent Past, Current & Future Analysis for

4 of 16

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs